Unigene Laboratories Inc., a biopharmaceutical company, was incorporated in the State of Delaware in 1980. Our single business segment focuses on the research, production and drug delivery of small proteins, referred to as peptides, for therapeutic use. We have patented oral and nasal drug delivery technologies that have been shown to deliver therapeutically useful amounts of various peptides into the bloodstream, as well as manufacturing technologies for producing certain natural therapeutic peptides cost-effectively. Collectively, we brand our patented therapeutic peptide drug delivery and manufacturing technologies as “Peptelligence™”. We have three operating locations: administrative and regulatory offices in Boonton, New Jersey; a laboratory research facility in Fairfield, New Jersey; and a pharmaceutical production facility in Boonton, New Jersey.